[Extemporaneous histologic examination in infraclinical mammary lesions]

Current quality challenges in H&E preparation: The critical foundation for increased use of digital pathology and AI emergence.

Virchows Archiv : an international journal of pathology·2026

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

The Lancet. Oncology·2026

Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial.

Breast (Edinburgh, Scotland)·2026

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

European urology oncology·2026

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Breast (Edinburgh, Scotland)·2026

Hospitalization at home use analysis for immune checkpoint inhibitors administrations in France: Care pathways, costs and development opportunities.

Bulletin du cancer·2026

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Bulletin du cancer·2026

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

Bulletin du cancer·2026

French treatment recommendations for malignant non-seminomatous germ cell tumours in children and adolescents.

Bulletin du cancer·2026

A comprehensive review on the molecular basis and therapeutic potential of UBE2M in cancer.

Bulletin du cancer·2026

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Bulletin du cancer·2026

Spatial immune biomarkers in triple-negative breast cancer: emerging evidence, technology trade-offs, and barriers to clinical translation.

Frontiers in immunology·2026

Revisiting the immunosuppressive microenvironment in hepatocellular carcinoma: a functional taxonomy of immune cells and therapeutic targeting.

Cancer biology & medicine·2026

Muscle-invasive urothelial carcinoma of the bladder in a direct inguinal hernia.

BMJ case reports·2026

TREM2⁺ tumor-associated macrophages in cancer: context-dependent biology, biomarkers and precision immunotherapy.

Critical reviews in oncology/hematology·2026

STING Expression in Pituitary Neuroendocrine Tumour Immune Microenvironments.

Endocrine-related cancer·2026

Immune dysregulation and stem-like CD8+ T cell enrichment in type 1 diabetes pancreatic lymph nodes.

The Journal of clinical investigation·2026

Related Experiment Videos

[Extemporaneous histologic examination in infraclinical mammary lesions]

Related Concept Videos

Current quality challenges in H&E preparation: The critical foundation for increased use of digital pathology and AI emergence.

Clinical outcomes and prognostic factors in advanced high-grade platinum-resistant ovarian carcinoma: evidence from the ESME real-world cancer database.

Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial.

FGFR3 Testing in Urothelial Carcinoma: An Expert Commentary on Best Practices From Patient Identification to Result Reporting.

Tucatinib in patients with HER2-positive advanced/metastatic breast cancer: A systematic literature review of real-world evidence.

Hospitalization at home use analysis for immune checkpoint inhibitors administrations in France: Care pathways, costs and development opportunities.

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

French treatment recommendations for malignant non-seminomatous germ cell tumours in children and adolescents.

A comprehensive review on the molecular basis and therapeutic potential of UBE2M in cancer.

Cervical cancer in French Guiana before the implementation of the University Hospital: Outcome and prognosis.

Spatial immune biomarkers in triple-negative breast cancer: emerging evidence, technology trade-offs, and barriers to clinical translation.

Revisiting the immunosuppressive microenvironment in hepatocellular carcinoma: a functional taxonomy of immune cells and therapeutic targeting.

Muscle-invasive urothelial carcinoma of the bladder in a direct inguinal hernia.

TREM2⁺ tumor-associated macrophages in cancer: context-dependent biology, biomarkers and precision immunotherapy.

STING Expression in Pituitary Neuroendocrine Tumour Immune Microenvironments.

Immune dysregulation and stem-like CD8+ T cell enrichment in type 1 diabetes pancreatic lymph nodes.

Related Experiment Videos

[Extemporaneous histologic examination in infraclinical mammary lesions]

Related Concept Videos

Related Articles